Results 11 to 20 of about 41,209 (140)
Passive immunization with influenza haemagglutinin specific monoclonal antibodies [PDF]
Human Vaccines & Immunotherapeutics, 2018 The isolation of broadly neutralising antibodies against the influenza haemagglutinin has spurred investigation into their clinical potential, and has led to advances in influenza virus biology and universal influenza vaccine development.
Rajeev Rudraraju, Kanta Subbarao
doaj +2 more sources
Passive immunization and its rebirth in the era of the COVID-19 pandemic [PDF]
International Journal of Antimicrobial Agents, 2021 Charles S Pavia
exaly +2 more sources
Passive Immunity and Antibody Response Induced by Toxoplasma gondii VLP Immunization
Vaccines, 2021 Passive immunity can provide immediate protection against infectious pathogens. To date, only a few studies have investigated the effect of passive immunization against Toxoplasma gondii, and the use of immune sera acquired from VLP-vaccinated mice for ...
Hae-Ji Kang +5 more
doaj +1 more source
Duration of Passive Immunity [PDF]
Journal of Hygiene, 1922 1. The course of elimination of passive immunity in rabbits injected intravenously with diphtheria antitoxin obtained from a horse, consists of three phases:(a) an initial loss of 50 per cent, occurring within the first 24 hours;(6) a gradual constant percentage loss of approximately 25 per cent, from day to day, lasting 6–7 days;(c) a rapidly ...
A T, Glenny, B E, Hopkins
openaire +3 more sources
The biophysical principles underpinning muco-trapping functions of antibodies
Human Vaccines & Immunotherapeutics, 2022 In addition to the classical immunological functions such as neutralization, antibody-dependent cellular cytotoxicity, and complement activation, IgG antibodies possess a little-recognized and under-utilized effector function at mucosal surfaces ...
Alison Schaefer, Samuel K. Lai
doaj +1 more source
Passive Immunity to Poliomyelitis in the Chimpanzee [PDF]
The Journal of Nervous and Mental Disease, 1945 A series of 6 chimpanzees was inoculated orally with stool from a poliomyelitis patient. Three of these animals had been given 170 cc. of homologous, hyperimmune monkey serum prior to inoculation, while three were unprotected. All 6 of the animals were subsequently shown to have poliomyelitis virus in their stools and ...
H A, Howe, D, Bodian
openaire +2 more sources
Frontiers in Microbiology, 2018 New therapies are needed to prevent and treat Clostridium difficile infection and to limit the rise in antibiotic resistance. Besides toxins, several surface components have been characterized as colonization factors and have been shown as immunogenic ...
Séverine Péchiné +3 more
doaj +1 more source
Using Monoclonal Antibodies to Prevent Mucosal Transmission of Epidemic Infectious Diseases
Emerging Infectious Diseases, 1999 Passive immunization with antibodies has been shown to prevent a wide variety of diseases. Recent advances in monoclonal antibody technology are enabling the development of new methods for passive immunization of mucosal surfaces.
Larry Zeitlin +2 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2023 New technologies for the prevention of infectious diseases are emerging to address unmet medical needs, in particular, the use of long-acting monoclonal antibodies (mAb) to prevent Respiratory Syncytial Virus (RSV) lower respiratory tract disease in ...
Catherine Weil-Olivier +7 more
doaj +1 more source